CTMX
CytomX Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.98 / 10
Netural
CTMX's fundamental assessment is poor (4.0/10). Key concerns include a -24.47% YoY revenue decline and negative Net income-Revenue, signaling operational challenges. Strengths are limited to a healthy Days sales outstanding (8.46) and an Interest coverage ratio of 15.48, which support liquidity. Overall, the balance of factors suggests prudent investment with close monitoring of financial health.
Analysis Checks(9/10)
Revenue-MV
Value-2.57
Score2/3
Weight13.97%
1M Return7.73%
Value-2.57
Score2/3
Weight13.97%
1M Return7.73%
Days sales outstanding
Value8.46
Score2/3
Weight1.55%
1M Return1.10%
Value8.46
Score2/3
Weight1.55%
1M Return1.10%
Net income-Revenue
Value-0.17
Score3/3
Weight16.94%
1M Return9.29%
Value-0.17
Score3/3
Weight16.94%
1M Return9.29%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.42%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.42%
1M Return-1.11%
Asset-MV
Value-0.50
Score2/3
Weight18.36%
1M Return10.15%
Value-0.50
Score2/3
Weight18.36%
1M Return10.15%
Total operating revenue (YoY growth rate %)
Value-24.47
Score2/3
Weight1.52%
1M Return1.11%
Value-24.47
Score2/3
Weight1.52%
1M Return1.11%
Profit-MV
Value-0.30
Score3/3
Weight17.16%
1M Return9.28%
Value-0.30
Score3/3
Weight17.16%
1M Return9.28%
PB-ROE
Value2.13
Score1/3
Weight17.34%
1M Return9.57%
Value2.13
Score1/3
Weight17.34%
1M Return9.57%
Operating revenue (YoY growth rate %)
Value-24.47
Score2/3
Weight0.59%
1M Return0.43%
Value-24.47
Score2/3
Weight0.59%
1M Return0.43%
Cash-MV
Value-0.07
Score2/3
Weight14.00%
1M Return8.41%
Value-0.07
Score2/3
Weight14.00%
1M Return8.41%
Revenue-MV
Value-2.57
Score2/3
Weight13.97%
1M Return7.73%
Value-2.57
Score2/3
Weight13.97%
1M Return7.73%
Total operating revenue (YoY growth rate %)
Value-24.47
Score2/3
Weight1.52%
1M Return1.11%
Value-24.47
Score2/3
Weight1.52%
1M Return1.11%
Days sales outstanding
Value8.46
Score2/3
Weight1.55%
1M Return1.10%
Value8.46
Score2/3
Weight1.55%
1M Return1.10%
Profit-MV
Value-0.30
Score3/3
Weight17.16%
1M Return9.28%
Value-0.30
Score3/3
Weight17.16%
1M Return9.28%
Net income-Revenue
Value-0.17
Score3/3
Weight16.94%
1M Return9.29%
Value-0.17
Score3/3
Weight16.94%
1M Return9.29%
PB-ROE
Value2.13
Score1/3
Weight17.34%
1M Return9.57%
Value2.13
Score1/3
Weight17.34%
1M Return9.57%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.42%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.42%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value-24.47
Score2/3
Weight0.59%
1M Return0.43%
Value-24.47
Score2/3
Weight0.59%
1M Return0.43%
Asset-MV
Value-0.50
Score2/3
Weight18.36%
1M Return10.15%
Value-0.50
Score2/3
Weight18.36%
1M Return10.15%
Cash-MV
Value-0.07
Score2/3
Weight14.00%
1M Return8.41%
Value-0.07
Score2/3
Weight14.00%
1M Return8.41%
Is CTMX fundamentally strong?
- CTMX scores 3.98/10 on fundamentals and holds a Fair valuation at present. Backed by its 17.10% ROE, 24.66% net margin, 20.02 P/E ratio, 8.95 P/B ratio, and 87.50% earnings growth, these metrics solidify its Netural investment rating.
